Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    Chocolate Bar Registry
Previous Study | Return to List | Next Study

Chocolate Balloon Angioplasty Registry (Chocolate BAR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2012 by TriReme Medical, LLC
Sponsor:
Information provided by (Responsible Party):
TriReme Medical, LLC
ClinicalTrials.gov Identifier:
NCT01589042
First received: April 27, 2012
Last updated: December 5, 2012
Last verified: December 2012

April 27, 2012
December 5, 2012
May 2012
Not Provided
Achievement of Optimal PTA [ Time Frame: average of 2 hours ] [ Designated as safety issue: Yes ]
Percentage of PTA cases in which <30% diameter stenosis without a flow limiting dissection is achieved without the need for bail-out stenting
Same as current
Complete list of historical versions of study NCT01589042 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Chocolate Balloon Angioplasty Registry
Chocolate Balloon Angioplasty Registry

To collect data from real-world use with the Chocolate PTA Balloon Catheter to support the effectiveness of the device for use during percutaneous transluminal angioplasty (PTA) procedures.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients with Peripheral Arterial Disease appropriate for treatment with balloon angioplasty

Peripheral Arterial Disease
Not Provided
  • Above the Knee
    Patients treated with the Chocolate balloon for a lesion located above the knee
  • Below the Knee
    Patients treated with the Chocolate balloon for a lesion located below the knee
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
Not Provided
Not Provided

Inclusion Criteria:

  1. >18 years of age
  2. Lesion successfully crossed with a guide-wire
  3. Reference Vessel Diameter (RVD) within the treatment range of the Chocolate PTA Catheter used at the target lesion appropriate for 1:1 dilatation
  4. Patient has given consent for their information to be submitted to this registry

Exclusion Criteria:

  1. Lesion required stenting as the primary treatment approach
  2. Life expectancy <12 months
  3. Patient is enrolled in another clinical study that may impact the results of this registry
Both
18 Years and older
No
Contact: Erin Tims, MS 925-931-1300 ext 212 etims@trirememedical.com
United States
 
NCT01589042
CLP782
No
TriReme Medical, LLC
TriReme Medical, LLC
Not Provided
Principal Investigator: Jihad Mustapha, MD Metro Health Hospital
Principal Investigator: Lawrence Garcia, MD St Elizabeth's Med Center / Tufts Univ School of Medicine
TriReme Medical, LLC
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP